Registered dietitian Ayla Barmmer told The Post that about 15% of her patients taking GLP-1 medications have struggled to ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of ...

A postcode lottery means the £77-a-month drug is available to certain patients in Scotland and Wales, but not in England.